# Role of a Combination of Nutraceuticals (Ritmonutra) on Benign Supraventricular and Ventricular Arrhythmias

Study · id `cardio:ct-nct01647984` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01647984](<https://clinicaltrials.gov/study/NCT01647984>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01647984

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1500 participants.

## Technical summary

Registry record NCT01647984. Randomized; double masking; primary purpose prevention. Start 2012-12 (registry gives no type); primary completion 2014-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 1500 participants (enrolled count; ClinicalTrials.gov record NCT01647984, source copy `cardio:ctgov-nct01647984-2016-02-03`, retrieved 2026-10-26)
- Start date: 2012-12 (registry gives no type) (ClinicalTrials.gov record NCT01647984, source copy `cardio:ctgov-nct01647984-2016-02-03`, retrieved 2026-10-26)
- Primary completion: 2014-02 (actual) (ClinicalTrials.gov record NCT01647984, source copy `cardio:ctgov-nct01647984-2016-02-03`, retrieved 2026-10-26)
- Completion: 2014-12 (actual) (ClinicalTrials.gov record NCT01647984, source copy `cardio:ctgov-nct01647984-2016-02-03`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT01647984, source copy `cardio:ctgov-nct01647984-2016-02-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01647984-2016-02-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Role of a Combination of Nutraceuticals (Ritmonutra) on Benign Supraventricular and Ventricular Arrhythmias
- Condition: Ventricular and Atrial Extrasytoles
- Intervention (Dietary supplement): Ritmonutra
- Intervention (Dietary supplement): placebo
- Lead sponsor: Federico II University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry lists this organization as the lead sponsor: Federico II University (`cardio:org-federico-ii-university`)

## Provenance

Content hash: c563321be054e2590e3f5c1289779de85003aa6a51c8894f3aaa82c96c9eade0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
